Patents by Inventor Hyun-Jun Youn

Hyun-Jun Youn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ?-galactosylceramide derivatives, pharmaceutically acceptable salts thereof, preparation method and pharmaceutical composition for the immune adjuvant containing the same as an active ingredient
    Patent number: 8883746
    Abstract: Disclosed are novel ?-galactosylceramide derivatives, pharmaceutically acceptable salts thereof, preparation methods thereof, and pharmaceutical compositions for use in an immune adjuvant containing the same as an active ingredient. The derivatives, in which the amide moiety of ?-GalCer is bioisosterically replaced with a triazole moiety, direct cytokine secretion toward IL-4 rather than IFN-?and thus can be used as a therapeutic for autoimmune diseases regulated by IL-4, such as type 1 diabetes and multiple sclerosis.
    Type: Grant
    Filed: December 27, 2007
    Date of Patent: November 11, 2014
    Assignee: SNU R&DB Foundation
    Inventors: Chang-Yuil Kang, SangHee Kim, Hyun-Jun Youn, Yoon-Sook Lee, Kyoo-A Lee, Taeho Lee, Dong Jae Baek, Minjae Cho
  • ALPHA-GALACTOSYLCERAMIDE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION FOR THE IMMUNE ADJUVANT CONTAINING THE SAME AS AN ACTIVE INGREDIENT
    Publication number: 20100104590
    Abstract: Disclosed are novel ?-galactosylceramide derivatives, pharmaceutically acceptable salts thereof, preparation methods thereof, and pharmaceutical compositions for use in an immune adjuvant containing the same as an active ingredient. The derivatives, in which the amide moiety of ?-GalCer is bioisosterically replaced with a triazole moiety, direct cytokine secretion toward IL-4 rather than IFN-? and thus can be used as a therapeutic for autoimmune diseases regulated by IL-4, such as type 1 diabetes and multiple sclerosis.
    Type: Application
    Filed: December 27, 2007
    Publication date: April 29, 2010
    Applicant: SNU R&DB FOUNDATION
    Inventors: Chang-Yuil Kang, SangHee Kim, Hyun-Jun Youn, Yoon-Sook Lee, Kyoo-A Lee, Taeho Lee, Dong Jae Baek, Minjae Cho